Novo Nordisk A/S (NYSE:NVO) is one of the best affordable long term stocks to buy according to hedge funds. On February 5, Novo Nordisk A/S (NYSE:NVO) said it would take legal action against Hims & Hers after the telehealth company announced plans to sell compounded versions of Wegovy at $49 per month. Novo Nordisk called the move illegal mass compounding that threatens patient safety and said it would pursue legal and regulatory steps to protect patients and its intellectual property, noting it is the onl ...